Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Dimethyl Fumarate

Brand: 
NICE TA: 320
Indication: Treating relapsing‑remitting multiple sclerosis (NICE TA320)
Disease category: Malignant disease and immunosuppression
Commissioning responsibility: NHS England
PbR excluded: Yes

Background

Dimethyl fumarate is recommended as an option for treating adults with active relapsing‑remitting multiple sclerosis (normally defined as 2 clinically significant relapses in the previous 2 years), only if:
•they do not have highly active or rapidly evolving severe relapsing‑remitting multiple sclerosis and
•the manufacturer provides dimethyl fumarate with the discount agreed in the patient access scheme.
People currently receiving treatment initiated within the NHS with dimethyl fumarate that is not recommended for them by NICE in this guidance should be able to continue treatment until they and their NHS clinician consider it appropriate to stop.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red